Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Cirrhosis”

135 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 135 results

Not applicableActive Not RecruitingNCT04820036
What this trial is testing

A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)Endoscopic Sleeve GastroplastyNon-alcoholic Fatty Liver Disease (NAFLD)+4 more
Brigham and Women's Hospital 20
Post-approval studies (Phase 4)Ended earlyNCT02034279
What this trial is testing

The INFECIR-2 Albumin Prevention Study

Who this might be right for
Advanced Chronic Liver DiseaseUrinary InfectionPneumonia+2 more
EASL - CLIF Consortium 136
Not applicableStudy completedNCT03246048
What this trial is testing

Long Term Follow-up of Hepatitis C Cured Patients

Who this might be right for
Chronic Hepatitis CChronic Liver DiseaseCirrhosis
Hospital Universitari Vall d'Hebron Research Institute 300
Early research (Phase 1)Ended earlyNCT03059147
What this trial is testing

Phase 1 Study of SF1126 in Combination With Nivolumab in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
SignalRX Pharmaceuticals, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00154492
What this trial is testing

Use of NovoSeven® in Active Variceal Bleeding

Who this might be right for
Acquired Bleeding DisorderCirrhosis
Novo Nordisk A/S 265
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06648525
What this trial is testing

Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Harbin Medical University 68
Not applicableLooking for participantsNCT07042308
What this trial is testing

Natural History of Advanced Chronic Liver Diseases

Who this might be right for
CirrhosisAdvanced Chronic Liver Disease
Chinese University of Hong Kong 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT05402371
What this trial is testing

Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Fibrosis, LiverNAFLD
Hepion Pharmaceuticals, Inc. 120
Not applicableStudy completedNCT04146636
What this trial is testing

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients (IMPROVE Study)

Who this might be right for
NAFLDAlcohol-Related DisorderLiver Fibrosis
University Hospital, Angers 282
Not applicableStudy completedNCT02628717
What this trial is testing

Interferon/Ribavirin-Free Sofosbuvir Based Treatment (AURIC)

Who this might be right for
Chronic Hepatitis CCirrhosis
Medical University of Vienna 558
Testing effectiveness (Phase 2)Active Not RecruitingNCT06777316
What this trial is testing

An FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)CholangiocarcinomaOther Solid Tumors, Adult+9 more
Cogent Biosciences, Inc. 110
Large-scale testing (Phase 3)Not Yet RecruitingNCT07328919
What this trial is testing

Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Advanced Cholangiocarcinoma
TransThera Sciences (Nanjing), Inc. 138
Large-scale testing (Phase 3)Looking for participantsNCT04971577
What this trial is testing

Efficacy of Simvastatin in Alcoholic Liver Fibrosis

Who this might be right for
Liver FibrosisAlcohol Abuse
Anna Cruceta 90
Not applicableActive Not RecruitingNCT06604923
What this trial is testing

PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobiliary System in Patients With Primary Biliary Cholangitis Before and After Treatment.

Who this might be right for
Primary Biliary Cholangitis (PBC)CirrhosisCholestasis+2 more
University of Aarhus 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07042919
What this trial is testing

Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaCirrhosisStage III Hepatocellular Carcinoma AJCC v8+1 more
Northwestern University 53
Post-approval studies (Phase 4)Study completedNCT04218695
What this trial is testing

Prophylactic Antibiotics in Admitted Cirrhotics

Who this might be right for
Cirrhosis, Liver
Beth Israel Deaconess Medical Center 32
Post-approval studies (Phase 4)Study completedNCT00968695
What this trial is testing

Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites.

Who this might be right for
CirrhosisAscites
Instituto Grifols, S.A. 33
Post-approval studies (Phase 4)Study completedNCT00570622
What this trial is testing

Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis

Who this might be right for
CirrhosisAscitesPortal Hypertension
Medical University of Vienna 20
Post-approval studies (Phase 4)UnknownNCT02837302
What this trial is testing

Branched-chain Amino Acid (BCAA) on Progression of Advanced Liver Disease

Who this might be right for
Liver Cirrhosis
Kyungpook National University Hospital 1,470
Not applicableLooking for participantsNCT03472157
What this trial is testing

Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients

Who this might be right for
SurgeryObesityNASH - Nonalcoholic Steatohepatitis+1 more
University Hospital, Lille 100
Load More Results